112 related articles for article (PubMed ID: 1320272)
1. Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat models.
Groopman JD; Roebuck BD; Kensler TW
Prog Clin Biol Res; 1992; 374():139-55. PubMed ID: 1320272
[TBL] [Abstract][Full Text] [Related]
2. Do aflatoxin-DNA adduct measurements in humans provide accurate data for cancer risk assessment?
Groopman JD
IARC Sci Publ; 1988; (89):55-62. PubMed ID: 3143672
[TBL] [Abstract][Full Text] [Related]
3. The use of monoclonal antibody affinity columns for assessing DNA damage and repair following exposure to aflatoxin B1.
Groopman JD; Kensler TW
Pharmacol Ther; 1987; 34(2):321-34. PubMed ID: 3120202
[TBL] [Abstract][Full Text] [Related]
4. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China.
Groopman JD; Zhu JQ; Donahue PR; Pikul A; Zhang LS; Chen JS; Wogan GN
Cancer Res; 1992 Jan; 52(1):45-52. PubMed ID: 1727385
[TBL] [Abstract][Full Text] [Related]
5. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
[TBL] [Abstract][Full Text] [Related]
6. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography.
Groopman JD; Hasler JA; Trudel LJ; Pikul A; Donahue PR; Wogan GN
Cancer Res; 1992 Jan; 52(2):267-74. PubMed ID: 1728400
[TBL] [Abstract][Full Text] [Related]
7. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
[TBL] [Abstract][Full Text] [Related]
8. Molecular dosimetry of urinary aflatoxin-N7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats.
Groopman JD; DeMatos P; Egner PA; Love-Hunt A; Kensler TW
Carcinogenesis; 1992 Jan; 13(1):101-6. PubMed ID: 1733561
[TBL] [Abstract][Full Text] [Related]
9. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer.
Groopman JD; Wang JS; Scholl P
Can J Physiol Pharmacol; 1996 Feb; 74(2):203-9. PubMed ID: 8723033
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD
Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans.
Groopman JD; Wild CP; Hasler J; Junshi C; Wogan GN; Kensler TW
Environ Health Perspect; 1993 Mar; 99():107-13. PubMed ID: 8319607
[TBL] [Abstract][Full Text] [Related]
12. Aflatoxins as risk factors for hepatocellular carcinoma in humans.
Wogan GN
Cancer Res; 1992 Apr; 52(7 Suppl):2114s-2118s. PubMed ID: 1311989
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans.
McGlynn KA; Hunter K; LeVoyer T; Roush J; Wise P; Michielli RA; Shen FM; Evans AA; London WT; Buetow KH
Cancer Res; 2003 Aug; 63(15):4594-601. PubMed ID: 12907637
[TBL] [Abstract][Full Text] [Related]
14. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.
Bolton MG; Muñoz A; Jacobson LP; Groopman JD; Maxuitenko YY; Roebuck BD; Kensler TW
Cancer Res; 1993 Aug; 53(15):3499-504. PubMed ID: 8339253
[TBL] [Abstract][Full Text] [Related]
15. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
16. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
Kensler TW; Egner PA; Davidson NE; Roebuck BD; Pikul A; Groopman JD
Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884
[TBL] [Abstract][Full Text] [Related]
17. Impacts of chemicals on liver cancer risk.
Wogan GN
Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069
[TBL] [Abstract][Full Text] [Related]
18. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.
Roebuck BD; Liu YL; Rogers AE; Groopman JD; Kensler TW
Cancer Res; 1991 Oct; 51(20):5501-6. PubMed ID: 1680553
[TBL] [Abstract][Full Text] [Related]
19. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1.
Croy RG; Wogan GN
Cancer Res; 1981 Jan; 41(1):197-203. PubMed ID: 7448760
[TBL] [Abstract][Full Text] [Related]
20. Exposure biomarkers in chemoprevention studies of liver cancer.
Wild CP; Turner PC
IARC Sci Publ; 2001; 154():215-22. PubMed ID: 11220661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
